tirzepatide phase 2 Today, we reported positive EMBRAZE trial results demonstrating statistically significant preservation of lean mass with our investigational treatment apitegromab during tirzepatide-induced… | Scholar Rock Tirzepatide monotherapy in Chinese patients
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























